Atlas Trials

Study Evaluating the Efficacy of 90Yttrium-epratuzumab in Adults With CD22+ Relapsed/Refractory B-ALL

Clinical trial NCT02844530 · WITHDRAWN

Trial details

NCT number
NCT02844530
Sponsor
Nantes University Hospital
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
CD22+ Relapsed/Refractory B-ALL
Primary completion
2017-01-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.